As of June 2024 Acceleron Pharma has a market cap of $10.93 Billion. This makes Acceleron Pharma the world's 1525th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $10.93 B | 0% |
2021 | $10.93 B | 41.81% |
2020 | $7.70 B | 173.68% |
2019 | $2.81 B | 39.81% |
2018 | $2.01 B | 4.94% |
2017 | $1.91 B | 99.29% |
2016 | $0.96 B | -40.7% |
2015 | $1.62 B | 28.56% |
2014 | $1.26 B | 12.56% |
2013 | $1.12 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $351.25 B | 3,113.21% | ๐บ๐ธ USA |
![]() Pfizer PFE | $152.88 B | 1,298.56% | ๐บ๐ธ USA |
![]() Amgen AMGN | $162.69 B | 1,388.25% | ๐บ๐ธ USA |
![]() Regeneron Pharmaceuticals REGN | $115.18 B | 953.69% | ๐บ๐ธ USA |
![]() Sangamo Therapeutics
SGMO | $85.82 M | -99.21% | ๐บ๐ธ USA |
![]() Onconova Therapeutics ONTX | $20.9 M | -99.81% | ๐บ๐ธ USA |
![]() bluebird bio
BLUE | $0.18 B | -98.32% | ๐บ๐ธ USA |